APA (7th ed.) Citation

Chenglin Wu, Cong Xi, Junhua Tong, Jing Zhao, Hualiang Jiang, Jiang Wang, . . . Hong Liu. (2019). Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia. Elsevier.

Chicago Style (17th ed.) Citation

Chenglin Wu, Cong Xi, Junhua Tong, Jing Zhao, Hualiang Jiang, Jiang Wang, Yiping Wang, and Hong Liu. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Modulators for the Treatment of Hyperlipidemia. Elsevier, 2019.

MLA (9th ed.) Citation

Chenglin Wu, et al. Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as Proprotein Convertase Subtilisin/kexin Type 9 (PCSK9) Modulators for the Treatment of Hyperlipidemia. Elsevier, 2019.